PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.06 - 0.06
0.06 - 0.24
8.7K / 3.59M (Avg.)
-1.55 | -0.04
These metrics indicate whether the stock trades cheaply or expensively relative to its fundamentals. Value investors use them to find mispricings—buying stocks that appear undervalued, with solid long-term prospects and limited downside risk.
-1.22
Negative P/E while CRN.AX shows 7.70. Joel Greenblatt would examine path to profitability versus competitor.
1.53
P/S less than half of CRN.AX's 3.09. Joel Greenblatt would verify if margins support this discount.
153.77
P/B above 1.5x CRN.AX's 2.28. Michael Burry would check for potential asset overvaluation.
-6.23
Negative FCF while CRN.AX shows P/FCF of 34.31. Joel Greenblatt would examine cash flow improvement potential.
23.47
P/OCF 1.1-1.25x CRN.AX's 21.33. Bill Ackman would demand evidence of superior operating efficiency.
153.77
Fair value ratio above 1.5x CRN.AX's 2.18. Michael Burry would check for mean reversion risks.
-20.43%
Negative earnings while CRN.AX shows yield of 3.25%. Joel Greenblatt would examine path to profitability.
-16.06%
Negative FCF while CRN.AX shows yield of 2.79%. Joel Greenblatt would examine cash flow improvement potential.